Why the study?
Are inflammatory mediators and matrix degrading enzymes associated with acute coronary syndrome, and how does early reperfusion therapy impact their circulating levels?
Are inflammatory mediators and matrix degrading enzymes associated with acute coronary syndrome, and how does early reperfusion therapy impact their circulating levels?
Elevated levels of IL-6, hs-CRP, and MMP-9 are associated with acute coronary syndrome and appear to be released from vulnerable plaque or necrotic myocardium, with levels increasing following reperfusion therapy.
No takes yet. Share an insight, caveat, or question.
May support biomarker monitoring in ACS without altering management; leaves open causal roles and therapeutic implications.
Shu et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: